Doppel

Cortemaggiore, Italy Founded: 1994 • Age: 32 yrs Acquired By Trilantic Europe
Doppel is engaged in pharmaceutical production and research services.

About Doppel

Doppel is a Healthcare company based in Cortemaggiore (Italy) founded in 1994, and was acquired by Trilantic Europe in July 2015. Doppel is engaged in pharmaceutical production and research services. It operates on a Professional Services and HealthTech model. Doppel has completed 1 acquisition, including Dietopack. Doppel offers products and services including Pharmaceutical Production, Packaging Solutions, Research & Development, and Startup & Academia Support. Its focus areas include Pharmaceuticals and Drug Manufacturing. Its legal entity is Doppel Farmaceutici S.r.l.

Company details

Doppel Farmaceutici S.r.l. is involved in the pharmaceutical industry, focusing on production, packaging, research, and development. Services are provided across various sectors including formulation, validation, and industrialization of drugs. Customized solutions are offered to clients, ensuring high-quality outputs through innovative technologies and specialized consultancy. Support is extended to startups and academic initiatives, fostering innovation in healthcare. Commitment to excellence is maintained through certified standards in drug manufacturing.

  • Headquarters Cortemaggiore, Italy
  • Stage Acquired
  • Sectors
    Healthcare
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website doppel.it
  • Social LinkedIn X
  • Acquired by Trilantic Europe (Jul 2015)
  • Legal Name Doppel Farmaceutici S.R.L.
Key Metrics

Products & Services of Doppel

Doppel offers a comprehensive portfolio of products and services, including Pharmaceutical Production, Packaging Solutions, Research & Development, and Startup & Academia Support.

Pharmaceutical Production
Manufacturing

Various pharmaceutical forms are produced for diverse applications.

Packaging Solutions
Packaging

Packaging services are provided for pharmaceutical product protection.

Research & Development
R&D

Innovative drug formulations are developed through advanced research.

Startup & Academia Support
Consulting

Support is offered to startups and academic projects.

Investors in Doppel

Doppel has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Trilantic Europe.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
PE firm invests in Europe
trilanticeurope.comLondon, United Kingdom
Premium access

Investor details for Doppel

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Doppel

Doppel has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dietopack.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Contract manufacturer of nutraceuticals
dietopack.itMedolla, Italy2000May 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Doppel

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Doppel

3 dated milestones of Doppel across 26 years, from founding to its latest funding, stage changes and deals.

  1. Founded Doppel is founded.
  2. Exit Acquired by Trilantic Europe.
  3. Acquisition Acquires Dietopack.

Web traffic of Doppel

Websites that share an audience with Doppel (doppel.it).

Similar websites

Websites whose visitors overlap most with Doppel. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
youtube.com
100%
30.4B#2View details
google.it
google.it
100%
–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Doppel

Premium access

Complete news archive for Doppel

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Doppel

Doppel was founded in 1994.

Doppel is headquartered in Cortemaggiore, Italy. It is registered at Cortemaggiore, Emilia-romagna, Italy.

Doppel Farmaceutici S.r.l. is involved in the pharmaceutical industry, focusing on production, packaging, research, and development. Services are provided across various sectors including formulation, validation, and industrialization of drugs. Customized solutions are offered to clients, ensuring high-quality outputs through innovative technologies and specialized consultancy. Support is extended to startups and academic initiatives, fostering innovation in healthcare. Commitment to excellence is maintained through certified standards in drug manufacturing.

Doppel offers Pharmaceutical Production, Packaging Solutions, Research & Development, and Startup & Academia Support.

Doppel has made 1 acquisition, including Dietopack.

Doppel has 1 investor. Key investors include Trilantic Europe.

Doppel operates through Doppel Farmaceutici S.R.L..

Yes. Doppel was acquired by Trilantic Europe in July 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available